## Spiko raises $90M Series B to scale tokenized cash funds
The raise
Paris- and London-based Spiko raised a $90M Series B led by NEA, first reported by Bloomberg on Oct 6, 2026 and confirmed by Spiko on X.
Total funding: $120M — per Spiko
Valuation: $800M post-money — per CEO Paul-Adrien Hyppolite in interview, per Bloomberg
Other backers: Index Ventures, Bpifrance, Speedinvest, White Star Capital, Wintermute Ventures, plus Flourish Ventures, Shapers, Blockwall, Frst, EQNX, Mirana Ventures — per Spiko; angels incl. ex-Bundesbank president Axel Weber and Qonto founders
Use of proceeds: new products, new markets, hires — building local teams across Europe (Germany, Nordics, Italy, Spain, Netherlands) — per Spiko
The business — tokenized money-market / cash funds
Scale claimed: $2.7B under management, 10,000+ businesses and individuals in 25+ countries/jurisdictions, up >5x in 12 months; Spiko's own X post on raise day says "nearly $3B" growing "15%+ a month"
Products: Smart Cash (day-to-day treasury) in Euro, Dollar, Pound, Swiss Franc, plus Government Money Market Funds / Spiko T-Bills for regulated uses like client-fund segregation — per Spiko
Backing: euro and US T-bills / risk-free assets; UCITS-approved, MiFID investment firm, bankruptcy-remote, with Amundi, PwC, CACEIS, Crédit Agricole / BNP Paribas as partners — per Spiko homepage
Onchain + programmable: fund shares recorded on public blockchains (same rails as stablecoins); instant withdrawals today, real-time interest accrual coming; rules via API / TMS / AI agents — e.g. auto-sweep spare cash, auto-withdraw for payroll — per Spiko
Rating: S&P Global Ratings AAAf / S1+ (highest on both scales) for eurSAFO, the euro share class — per Spiko on X
Competitive claim: Spiko says its tokenized cash-fund range is now larger than BlackRock's and Franklin Templeton's, citing RWA.xyz data.
The $2.7B AUM and customer figures are company-reported figures repeated in launch coverage; independent RWA.xyz pages checked did not expose Spiko-specific totals to verify them against.